The Karnataka Indian Medicine Manufacturers Association (KIMMA) has changed its name to Federation of Indian Ayush (FIA) industry and is outlining its scope and strategies to gain national recognition as it would now scout for members across the country representing Ayurveda, Siddha, Unani and Homoeopathy industry.
The key objective for a change of name is to broaden the scope of service to the industry. We have an uphill task before us but our effort is to build a strong team of young, energetic, industry members and put in place mechanisms for its effective implementation, said JSD Pani, president, KIMMA.
The decision was taken at KIMMA’s recently concluded annual general body meeting where its members mandated need for a name change in an effort to expand its involvement with Siddha, Unani and Homoeopathy, he added.
The Ayush sector has been gaining a status in the healthcare sector because of the nature of its offerings which are holistic in nature. Ayush and allopathy or modern system of medicine could complement each other in treatment and therapies. Further, Ayurveda is also credited to be the core of Indian systems of medicine. This led us to take up the cause of related specialties covering Siddha, Unani and Homoeopathy. As the Federation of Indian Ayush, we intent to strengthen the sector to meet challenges ahead, pointed out Pani.
At the general body meeting of KIMMA, its executive committee of 11 members were elected, besides re-electing JSD Pani as its president. For fiscal 2014- 2015, NB Ramgopal would be the vice president, Shylesh Pattavardhan general secretary, and MRE Naidu secretary and Anandkumar as treasurer.
Once the registration process is completed, the Federation of Ayush will take up events across the country and also request the existing associations of Ayush industry to apply for membership to this new body.
For over a decade, the union government too had changed its department from Indian System of Medicine to Ayush. Therefore, to be in sync with national developments, the state association too saw that a change of name was critical for its recognition at a time when the union government is giving impetus to this industry, said Pani.
Source:Pharmabiz
The key objective for a change of name is to broaden the scope of service to the industry. We have an uphill task before us but our effort is to build a strong team of young, energetic, industry members and put in place mechanisms for its effective implementation, said JSD Pani, president, KIMMA.
The decision was taken at KIMMA’s recently concluded annual general body meeting where its members mandated need for a name change in an effort to expand its involvement with Siddha, Unani and Homoeopathy, he added.
The Ayush sector has been gaining a status in the healthcare sector because of the nature of its offerings which are holistic in nature. Ayush and allopathy or modern system of medicine could complement each other in treatment and therapies. Further, Ayurveda is also credited to be the core of Indian systems of medicine. This led us to take up the cause of related specialties covering Siddha, Unani and Homoeopathy. As the Federation of Indian Ayush, we intent to strengthen the sector to meet challenges ahead, pointed out Pani.
At the general body meeting of KIMMA, its executive committee of 11 members were elected, besides re-electing JSD Pani as its president. For fiscal 2014- 2015, NB Ramgopal would be the vice president, Shylesh Pattavardhan general secretary, and MRE Naidu secretary and Anandkumar as treasurer.
Once the registration process is completed, the Federation of Ayush will take up events across the country and also request the existing associations of Ayush industry to apply for membership to this new body.
For over a decade, the union government too had changed its department from Indian System of Medicine to Ayush. Therefore, to be in sync with national developments, the state association too saw that a change of name was critical for its recognition at a time when the union government is giving impetus to this industry, said Pani.
Source:Pharmabiz
No comments:
Post a Comment